Cochrane Database of Systematic Reviews 2013
DOI: 10.1002/14651858.cd006569.pub4
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Aripiprazole versus other atypical antipsychotics for schizophrenia

Abstract: Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials.

Search citation statements

Order By: Relevance

Paper Sections

Select...
28
16
10
3

Citation Types

1
44
0
5

Year Published

Range
2014
2014
2025
2025

Publication Types

Select...
50
1
1

Relationship

0
52

Authors

Journals

citations

Cited by 52 publications

(50 citation statements)
references

References 94 publications

1
44
0
5
Order By: Relevance
How this paper cites the one you are viewing
“…Participants switched to aripiprazole at 24 weeks of follow-up had better triglyceride and fasting insulin values but not for total cholesterol or LDL cholesterol. Our prolactin findings favoring aripiprazole over risperidone are consistent with those from multiepisode comparison studies 6,20 and from studies of prolactin levels following switching from risperidone to aripiprazole. 22 Our study had limitations.…”
Section: Discussion
supporting
confidence: 86%